FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366774590> ?p ?o ?g. }

• W4366774590 endingPage "1061" @default.
• W4366774590 startingPage "1061" @default.
• W4366774590 abstract "Proteinuria is a major risk factor for the progression of chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) demonstrated a nephroprotective and antiproteinuric effect in people with type 2 diabetes (T2DM) and proteinuric CKD. We conducted a retrospective study to evaluate clinical and laboratory variables that can help predict proteinuria reduction with SGLT2i therapy.Patients affected by T2DM and CKD who started any SGLT2i were included in the study. Patients were stratified into two subgroups, Responder (R) and non-Responder (nR), based upon the response to the therapy with SGLT2i, namely the reduction in a 24 h urine proteins test (uProt) of ≥30% from baseline levels. The aim of the study is to analyse differences in baseline characteristics between the two groups and to investigate the relationship between them and the proteinuria reduction. A Kruskal-Wallis test, unpaired t-test and Chi2 test were used to test the difference in means and the percentage (%) between the two groups. Linear and logistic regressions were utilized to analyse the relationship between proteinuria reduction and basal characteristics.A total of 58 patients were enrolled in the study: 32 patients (55.1%) were in the R group and 26 patients (44.9%) in the nR group. R's patients had a significant higher uProt at baseline (1393 vs. 449 mg/24 h, p = 0.010). There was a significant correlation between baseline uProt and proteinuria reduction with SGLT2i in both univariate (β = -0.43, CI -0.55 to -031; p < 0.001) and multivariate analyses (β = -0.46, CI -0.57 to -0.35, p < 0.001). In the multivariate analysis, there was a significant positive correlation between the estimated glomerular filtration rate (eGFR) and proteinuria reduction (β = -17, CI -31 to -3.3, p = 0.016) and a significant negative correlation with body mass index (BMI) (β = 81, CI 13 to 50, p = 0.021). The multivariate logistic regressions show a positive correlation of being in the R group with diabetic retinopathy at baseline (Odds Ratio (OR) 3.65, CI 0.97 to 13.58, p = 0.054), while the presence of cardiovascular disease (CVD) at baseline is associated with being in the nR group (OR 0.34, CI 0.09 to 1.22, p = 0.1), even if these statements did not reach statistical significance.In this real-life experience, following the administration of SGLT2i, a reduction of more than 30% in proteinuria was observed in more than half of the patients, and these patients had a significantly higher baseline proteinuria value. Variables such as eGFR and BMI are variables that, considered in conjunction with proteinuria, can help predict treatment response before therapy initiation. Different phenotypes of diabetic kidney disease may have an impact on the antiproteinuric response." @default.
• W4366774590 created "2023-04-25" @default.
• W4366774590 creator A5004908196 @default.
• W4366774590 creator A5005564564 @default.
• W4366774590 creator A5009434668 @default.
• W4366774590 creator A5013538381 @default.
• W4366774590 creator A5015826182 @default.
• W4366774590 creator A5018656086 @default.
• W4366774590 creator A5018933068 @default.
• W4366774590 creator A5020771010 @default.
• W4366774590 creator A5035705338 @default.
• W4366774590 creator A5052463398 @default.
• W4366774590 creator A5070321335 @default.
• W4366774590 creator A5074062690 @default.
• W4366774590 date "2023-04-21" @default.
• W4366774590 modified "2023-10-01" @default.
• W4366774590 title "Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease" @default.
• W4366774590 cites W1540594287 @default.
• W4366774590 cites W1577181385 @default.
• W4366774590 cites W1672921524 @default.
• W4366774590 cites W1826211555 @default.
• W4366774590 cites W1906793157 @default.
• W4366774590 cites W1970024336 @default.
• W4366774590 cites W1990025047 @default.
• W4366774590 cites W2033905400 @default.
• W4366774590 cites W2050826908 @default.
• W4366774590 cites W2088462304 @default.
• W4366774590 cites W2094714692 @default.
• W4366774590 cites W2107031719 @default.
• W4366774590 cites W2119741758 @default.
• W4366774590 cites W2124602789 @default.
• W4366774590 cites W2130505638 @default.
• W4366774590 cites W2146264128 @default.
• W4366774590 cites W2153037249 @default.
• W4366774590 cites W2156758360 @default.
• W4366774590 cites W2170783508 @default.
• W4366774590 cites W2475261460 @default.
• W4366774590 cites W2565573690 @default.
• W4366774590 cites W2583476095 @default.
• W4366774590 cites W2588237306 @default.
• W4366774590 cites W2613483874 @default.
• W4366774590 cites W2615714795 @default.
• W4366774590 cites W2626446274 @default.
• W4366774590 cites W2733849831 @default.
• W4366774590 cites W2793364903 @default.
• W4366774590 cites W2900413769 @default.
• W4366774590 cites W2909182150 @default.
• W4366774590 cites W2920471770 @default.
• W4366774590 cites W2939203716 @default.
• W4366774590 cites W2939222610 @default.
• W4366774590 cites W2968423406 @default.
• W4366774590 cites W3008148226 @default.
• W4366774590 cites W3088173406 @default.
• W4366774590 cites W3089612515 @default.
• W4366774590 cites W3091878005 @default.
• W4366774590 cites W3131399962 @default.
• W4366774590 cites W3190177076 @default.
• W4366774590 cites W3196639761 @default.
• W4366774590 cites W3202330513 @default.
• W4366774590 cites W4200143795 @default.
• W4366774590 cites W4221068733 @default.
• W4366774590 cites W4224290456 @default.
• W4366774590 cites W4229011177 @default.
• W4366774590 cites W4280493909 @default.
• W4366774590 cites W4285719527 @default.
• W4366774590 cites W4293920968 @default.
• W4366774590 cites W4319826108 @default.
• W4366774590 doi "https://doi.org/10.3390/life13041061" @default.
• W4366774590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37109590" @default.
• W4366774590 hasPublicationYear "2023" @default.
• W4366774590 type Work @default.
• W4366774590 citedByCount "0" @default.
• W4366774590 crossrefType "journal-article" @default.
• W4366774590 hasAuthorship W4366774590A5004908196 @default.
• W4366774590 hasAuthorship W4366774590A5005564564 @default.
• W4366774590 hasAuthorship W4366774590A5009434668 @default.
• W4366774590 hasAuthorship W4366774590A5013538381 @default.
• W4366774590 hasAuthorship W4366774590A5015826182 @default.
• W4366774590 hasAuthorship W4366774590A5018656086 @default.
• W4366774590 hasAuthorship W4366774590A5018933068 @default.
• W4366774590 hasAuthorship W4366774590A5020771010 @default.
• W4366774590 hasAuthorship W4366774590A5035705338 @default.
• W4366774590 hasAuthorship W4366774590A5052463398 @default.
• W4366774590 hasAuthorship W4366774590A5070321335 @default.
• W4366774590 hasAuthorship W4366774590A5074062690 @default.
• W4366774590 hasBestOaLocation W43667745901 @default.
• W4366774590 hasConcept C126322002 @default.
• W4366774590 hasConcept C134018914 @default.
• W4366774590 hasConcept C151956035 @default.
• W4366774590 hasConcept C167135981 @default.
• W4366774590 hasConcept C2778653478 @default.
• W4366774590 hasConcept C2779561371 @default.
• W4366774590 hasConcept C2780091579 @default.
• W4366774590 hasConcept C50440223 @default.
• W4366774590 hasConcept C555293320 @default.
• W4366774590 hasConcept C71924100 @default.
• W4366774590 hasConcept C90924648 @default.
• W4366774590 hasConceptScore W4366774590C126322002 @default.

• next